UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002443
Receipt number R000002987
Scientific Title Is prophylactic use of antimicrobial agent effective in prevention of infectious complication after diagnostic bronchoscopy?
Date of disclosure of the study information 2009/09/04
Last modified on 2014/09/04 00:51:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Is prophylactic use of antimicrobial agent effective in prevention of infectious complication after diagnostic bronchoscopy?

Acronym

J-BRONCHO

Scientific Title

Is prophylactic use of antimicrobial agent effective in prevention of infectious complication after diagnostic bronchoscopy?

Scientific Title:Acronym

J-BRONCHO

Region

Japan


Condition

Condition

Diseases with the indication of bronchoscopic examination

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the risk of infectious complications in estimating relative risk comparing whether or not in prophylactic use of antimicrobial agent by a prospective cohort survey

Basic objectives2

Others

Basic objectives -Others

To estimate the rate of infectious complications

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Whether or not an antimicrobial agent was administered to the patients with infectious complications within one week after bronchoscopic examination

Key secondary outcomes

Whether of not any respiratory symptom, disturbance on the daily life, any consultation to the medical facility was recorded, and the maximum body temperature


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients with indications for bronchoscopic examination
2) Ages equal or over 20 years old
3) Written informed consent from the patient

Key exclusion criteria

1) Administration of antimicrobial agent within 7 days before examination
2) Therapeitic bronchoscopy
3) Diagnostic bronchoscopy for the confirmation of infectious disease
4) Rigid bronchoscopy
5) On-respirator, general surgery, toracheotomy, bronchoscopic examinations, bronshoscopic treatment within 1 week

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name HIDEO SAKA

Organization

National Hospital Organization, Nagoya Medical Center

Division name

Department of Respiratory Medicine

Zip code


Address

4-1-1 Sannomaru, Naka-ku, Nagoya

TEL

+81-52-951-1111

Email

saka@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name HIDEO SAKA

Organization

National Hospital Organization, Nagoya Medical Center

Division name

Department of Respiratory Medicine

Zip code


Address

4-1-1 Sannomaru, Naka-ku, Nagoya

TEL

+81-52-951-1111

Homepage URL


Email

saka@nagoya.hosp.go.jp


Sponsor or person

Institute

National Hospital Organization

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構名古屋医療センター他,59施設


Other administrative information

Date of disclosure of the study information

2009 Year 09 Month 04 Day


Related information

URL releasing protocol

http://www.csecr.jp/broncho.html

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2007 Year 07 Month 20 Day

Date of IRB


Anticipated trial start date

2007 Year 09 Month 01 Day

Last follow-up date

2009 Year 04 Month 01 Day

Date of closure to data entry

2009 Year 07 Month 01 Day

Date trial data considered complete

2009 Year 07 Month 01 Day

Date analysis concluded

2009 Year 11 Month 01 Day


Other

Other related information

A total of 5,213 cases entered


Management information

Registered date

2009 Year 09 Month 03 Day

Last modified on

2014 Year 09 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002987


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name